Integrated Proteins Limited has submitted its quarterly compliance certificate to BSE Limited in accordance with SEBI regulations for the quarter ended March 31, 2026. The submission fulfills the company's regulatory obligations under the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Submission

The certificate was submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, dated April 11, 2026. Managing Director Karanj Dharmeshbhai Doshi signed the submission letter to BSE Limited, ensuring proper documentation of the company's compliance status.

Registrar Confirmation

Cameo Corporate Services Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate on April 1, 2026. The certificate confirms that all securities received from depository participants for dematerialisation during the quarter were properly processed and confirmed to the depositories.

The registrar confirmed several key compliance aspects:

• Securities received for dematerialisation were accepted or rejected appropriately
• All securities in the certificates have been listed on stock exchanges where previously issued securities are traded
• Security certificates received for dematerialisation were mutilated and cancelled after proper verification
• Depository names were substituted in the register of members as registered owners within stipulated time limits

Corporate Information

Integrated Proteins Limited operates from Manek Centre, Office No 218, P N Marg, Jamnagar, Gujarat. The company maintains its corporate identification number as L62013GJ1992PLC018426 and trades on BSE with scrip code 519606. The quarterly submission demonstrates the company's commitment to maintaining regulatory compliance and transparent corporate governance practices.

Integrated Proteins Limited has issued a clarification to BSE Limited regarding recent significant movement observed in its share price, responding to an exchange inquiry dated March 2, 2026.

Company's Response to Price Movement Inquiry

The company addressed the BSE's concerns about unusual price activity in its securities through a formal communication dated March 10, 2026. Company Secretary Girish Kalwani signed the response, confirming the company's awareness of its regulatory obligations.

Regulatory Compliance Confirmation

Integrated Proteins emphasized its full compliance with disclosure requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated it has been regularly informing stock exchanges of all material events and price-sensitive information as mandated by applicable regulations.

After conducting due verification, the company confirmed it is not aware of any undisclosed events or information that could influence the price or volume behavior of its securities. The company assured that all material information requiring disclosure has already been shared with stock exchanges.

Market-Driven Movement Attribution

The company attributed the recent share price movement to market-driven factors and prevailing market conditions. Key points from the clarification include:

• No undisclosed material events affecting share price
• Movement appears purely market-driven
• Company not connected with price movement
• Full compliance with SEBI disclosure regulations maintained

The clarification serves to address investor concerns and maintain transparency regarding the company's securities trading activity.